The controlled presentation of TGF-β1 to hepatocytes in a 3D-microfluidic cell culture system
Authors:
- Ser-Mien ChiaSCSer-Mien Chia
- Siew-Min OngSOSiew-Min Ong
- Shufang ZhangSZShufang Zhang
- Yi-Chin TohYTYi-Chin Toh
- Danny van NoortDNDanny van Noort
- Hanry YuHYHanry Yu
- 1 August 2009
- journal article
- research article
- Published by Elsevier in Biomaterials
- Vol. 30 (23-24) , 3847-3853
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Proteolytic Enzyme Therapy in Evidence-Based Complementary Oncology: Fact or Fiction?Integrative Cancer Therapies, 2008
- A gel-free 3D microfluidic cell culture systemBiomaterials, 2008
- Controlled Release of Bioactive Transforming Growth Factor Beta-1 from Fibrin Gels In VitroTissue Engineering Part C: Methods, 2008
- Twenty-Eight-Day Oral Toxicity, Genotoxicity, and Gender-Related Tissue Distribution of Silver Nanoparticles in Sprague-Dawley RatsInhalation Toxicology, 2008
- Microfluidic platform for hepatitis B viral replication studyBiomedical Microdevices, 2007
- Lab-on-a-chip: microfluidics in drug discoveryNature Reviews Drug Discovery, 2006
- Exploring and Engineering the Cell Surface InterfaceScience, 2005
- Long-Term Maintenance of Cytochrome P450 Activities by Rat Hepatocyte/3T3 Cell Co-cultures in Heparinized Human PlasmaTissue Engineering, 2001
- Use of hepatocyte cultures for the study of hepatotoxic compoundsJournal of Hepatology, 1997
- Function of Culturing Monolayer Hepatocytes by Collagen Gel Coating and Coculture with Nonparenchymal CellsArtificial Organs, 1996